Hochtaunus-Kliniken gGmbH — Clinical Trial Site

7 Registered trials

3 Currently recruiting

Organisation

Hochtaunus-Kliniken gGmbH

Location

Bad Homburg, Germany

Identifier

ORG-100051587

Address

Zeppelinstrasse 20, 61352, Germany

Departments

Frauenklinik
Gynecology
Klinik für Gynäkologie und Geburtshilfe
Krankenhaus Bad Homburg Frauenklinik
n.a
Obstetrics and Gynaecology
Oncology Department

Clinical trials at this site (7)

Search interface

Evaluation of Niraparib alone compared to the combination of Niraparib and Bevacizumab in patients receiving chemotherapy for newly diagnose… Recruiting

2024-516066-11-00 Patients with newly diagnosed, histologically confirmed 5 2022-08-31
Phase 2 Study of Adagrasib Monotherapy and in Combination With Pembrolizumab and Phase 3 Study of Adagrasib in Combination with Pembrolizuma… Recruiting

2023-508922-83-00 Advanced Non-Small Cell Lung Cancer 10 2021-03-17
Pembrolizumab in combination with lenvatinib in patients with recurrent, persistent, metastatic or locally advanced vulvar cancer not amenab… Recruiting

2024-515646-16-00 Recurrent, persistent, metastatic or locally advanced v 4 2025-06-24
Study of Sacituzumab Govitecan Versus Treatment of Physician’s Choice in Participants With Endometrial Cancer After Platinum-Based Chemother… Ended

2024-511957-23-00 Recurrent or Persistent Endometrial Cancer 5 2025-01-03
A study to determine whether the addition of Dostarlimab (TSR-042) delays recurrence of advanced endometrial cancer Ended

2023-506551-23-00 Recurrent or primary advanced (Stage III or IV) endomet 5 2019-11-21
This is a phase III randomised, double-blind, placebo-controlled, multicentre, global study to assess the effectiveness and safety of standa… Ended

2022-502747-35-00 Newly diagnosed advanced (FIGO stage III-IV) high grade 5 2019-02-18
Chemotherapy plus Paclitaxel with Bevacizumab and Atezolizumab versus Chemotherapy plus Paclitaxel and Bevacizumab in Carcinoma of the Cervi… Ended

2024-514179-17-00 Metastatic (stage IVB), Persistent, or Recurrent Carcin 5 2018-10-02